These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 3005159
1. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam. Coutinho RA, Krone WJ, Smit L, Albrecht-van Lent P, van der Noordaa J, Schaesberg W, Goudsmit J. Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159 [Abstract] [Full Text] [Related]
2. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men. Jaffe HW, Feorino PM, Darrow WW, O'Malley PM, Getchell JP, Warfield DT, Jones BM, Echenberg DF, Francis DP, Curran JW. Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973 [Abstract] [Full Text] [Related]
3. Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. Weber JN, McCreaner A, Berrie E, Wadsworth J, Jeffries DJ, Pinching AJ, Harris JR. Genitourin Med; 1986 Jun; 62(3):177-80. PubMed ID: 3015772 [Abstract] [Full Text] [Related]
4. Relationship between antibody to LAV/HTLV-III and the natural course of subclinical cellular immune dysfunction in homosexual men. Collier AC, Meyers JD, Murphy VL, Roberts PL, Getchell JP, Handsfield HH. Sex Transm Dis; 1987 Jun; 14(1):1-8. PubMed ID: 3645805 [Abstract] [Full Text] [Related]
9. Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases. Burger H, Weiser B, Robinson WS, Lifson J, Engleman E, Rouzioux C, Brun-Vézinet F, Barré-Sinoussi F, Montagnier L, Chermann JC. Am J Med; 1986 Jul; 81(1):5-10. PubMed ID: 3014878 [Abstract] [Full Text] [Related]
10. Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome. Kaplan JE, Oleske JM, Getchell JP, Kalyanaraman VS, Minnefor AB, Zabala-Ablan M, Joshi V, Denny T, Cabradilla CD, Rogers MF. Pediatr Infect Dis; 1985 Jul; 4(5):468-71. PubMed ID: 2995933 [Abstract] [Full Text] [Related]
11. Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle. Collier AC, Barnes RC, Handsfield HH. Am J Public Health; 1986 May; 76(5):564-5. PubMed ID: 3008580 [Abstract] [Full Text] [Related]
18. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico]. Sierra Madero JG, Ponce de León S, Ruiz Palacios G, Tinoco JC, Calva JJ, Zamora EE. Salud Publica Mex; 1986 Jul 01; 28(2):180-5. PubMed ID: 3014666 [No Abstract] [Full Text] [Related]
20. Antibody to human T cell leukaemia virus type III in Australian homosexual men with lymphadenopathy. Frazer IH, Sarngadharan MG, Mackay IR, Gallo RC. Med J Aust; 1984 Sep 01; 141(5):274-6. PubMed ID: 6088957 [Abstract] [Full Text] [Related] Page: [Next] [New Search]